Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia
- 12 February 2014
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 61 (8) , 1416-1421
Abstract
Background: Central nervous system (CNS) involvement in childhood acute lymphoblastic leukemia (ALL) remains a therapeutic challenge.Procedure: To explore leukemia characteristics of patients with CNS involvement at ALL diagnosis, we analyzed clinical features and early treatment response of 744 patients on Nordic‐Baltic trials. CNS status was classified as CNS1 (no CSF blasts), CNS2 (P < 0.002). Patients with CNS3 more often had T‐ALL (P < 0.001) and t(9;22)(q34;q11)[BCR‐ABL1] (P < 0.004) compared with patients with CNS1. Among patients with CNS involvement headache (17%) and vomiting (14%) were most common symptoms. Symptoms or clinical findings were present among 27 of 54 patients with CNS3 versus only 7 of 39 patients with CNS2 and 15 of 75 patients with TLP+ (P < 0.001). The majority of patients with CNS involvement received additional induction therapy. The post induction bone marrow residual disease level did not differ between patients with CNS involvement and patients with CNS1 (P > 0.15). The 12‐year event‐free survival for patients with leukemic mass on neuroimaging did not differ from patients with negative or no scan (0.50 vs. 0.60; P = 0.7) or between patients with symptoms or signs suggestive of CNS leukemia and patients without such characteristics (0.50 vs. 0.61; P = 0.2).Conclusion: CNS involvement at diagnosis is associated with adverse prognostic features but does not indicate a less chemosensitive leukemia. Pediatr Blood Cancer 2014; 61:1416–1421.Keywords
This publication has 32 references indexed in Scilit:
- Hospital contact for mental disorders in survivors of childhood cancer and their siblings in Denmark: a population-based cohort studyThe Lancet Oncology, 2013
- Addition of serum-containing medium to cerebrospinal fluid prevents cellular loss over timeJournal of Neurology, 2011
- Detection of cancer cells in the cerebrospinal fluid: current methods and future directionsFluids and Barriers of the CNS, 2011
- Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906Pediatric Blood & Cancer, 2011
- Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881European Journal of Cancer, 2011
- Effect of delay in analysis on neonatal cerebrospinal fluid parametersArchives of Disease in Childhood - Fetal and Neonatal Edition, 2009
- Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical ApplicationsSeminars in Oncology, 2009
- Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood CancerJAMA, 2007
- Chronic Health Conditions in Adult Survivors of Childhood CancerNew England Journal of Medicine, 2006
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958